NCT00638937 2018-08-29AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination ChemotherapyNational Cancer Institute (NCI)Phase 2 Completed37 enrolled 13 charts
NCT00718809 2015-06-10Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic CancerNational Cancer Institute (NCI)Phase 2 Terminated21 enrolled 13 charts